J M Smith to acquire Burlington Drug
J M Smith Corp. plans to acquire drug wholesaler Burlington Drug Co. and certain retail operations assets of Pharmacy Health Services (PHS). Financial terms of the transaction weren’t disclosed.
Supplier News
HDA: Pharmacy chains still drug distributors’ top customer
Chain drug stores remain the largest customer base for pharmaceutical distributors, according to the Healthcare Distribution Alliance (HDA). Drug chains accounted for 42.
VoicePort teams up with iMedicare
VoicePort LLC has partnered with iMedicare to provide patient-specific Medicare plan analyses to community pharmacists via the VoicePort CLARO adherence application.
General Mills realigns global organization
General Mills has unveiled a new global organizational structure that eliminates a key international post and will result in hundreds of job cuts. The food company said Monday that it’s dropping the position of international chief operating officer.
Identigene acquired by DNA Diagnostics Center
DNA Diagnostics Center (DDC) has acquired at-home paternity test provider Identigene LLC. Financial terms of the transaction weren’t disclosed.
Akers Bio cholesterol test to get First Check branding
Akers Biosciences Inc. has entered an agreement with First Check Diagnostics LLC to exclusively distribute its rapid cholesterol self-test in the United States under the First Check brand.
McKesson to launch Central Fill as a Service
McKesson Corp.’s High Volume Solutions group is set to roll out Central Fill as a Service (CFaaS), a solution that gives pharmacies central-fill capability without the investment in equipment, inventory and extra staff.
Breckenridge Pharmaceutical to release Nuvigil generic
Breckenridge Pharmaceutical Inc. is launching armodafinil tablets (CIV), a medication for promoting wakefulness. Breckenridge said this week that its armodafinil product, which comes in strengths of 50 mg, 150 mg and 250 mg, is a generic version of Nuvigil from by Cephalon Inc.
Maura sharpens focus on Spectrum Brands
David Maura, executive chairman of Spectrum Brands Holdings Inc., has resigned from HRG Group Inc., which holds a majority stake in the company. Spectrum Brands said Maura’s departure from HRG, a diversified holding company, took effect Nov.
Omnicell unveils deal to acquire Ateb
Medication management and supply solution provider Omnicell Inc. plans to buy Ateb Inc., a specialist in patient care and medication synchronization services for pharmacies, in a $41 million deal.
Lannett set to release Skelaxin generic
Lannett Co. has gained Food and Drug Administration approval for metaxalone tablets 800 mg, a muscle relaxant. Lannett said Monday that its product is a generic version of Skelaxin tablets (800 mg) from King Pharmaceuticals Inc.
GSK’s FluLaval gains expanded age indication
GlaxoSmithKline has received approval from the Food and Drug Administration’s Center for Biologics Evaluation and Research expanding the indication for FluLaval Quadrivalent flu vaccine to include use in children ages 6 months and older.
Touch germ-killing hand spray grows retail presence
Relevo Labs continues to build retail distribution for its Touch Sanitizing Germ Block aerosol hand spray. The Carmel, Ind.-based company said Touch hand sanitizing spray — currently sold at Walgreens, CVS Pharmacy, Meijer and FedEx Office stores — is proven to kill 99.
H.D. Smith names Ross Davison as CFO
Ross Davison has joined H.D. Smith as chief financial officer. The drug wholesaler said Tuesday that Davison will oversee all of the company’s financial functions, including accounting, treasury, planning and budgeting, tax, risk management, corporate capital structuring and investor relations.
Ascensia to ship Contour Next One glucose system
Ascensia Diabetes Care has gained Food and Drug Administration 510(k) clearance for its Contour Next One blood glucose monitoring system. Ascensia said the approval marks a key step in making the Contour Next One available to Americans with diabetes.
Ateb partners with Improved Patient Outcomes
Ateb Inc. has teamed up with Improved Patient Outcomes Inc. to provide population health management solutions aimed at improving medication adherence via patient behavioral changes.